About Us

Eurofarma
Ventures

A forward-thinking corporate venture fund dedicated to advancing drug research and development.


Eurofarma Ventures, an integral part of Eurofarma Laboratorios's commitment to innovation, 
our mission is to drive groundbreaking advancements in drug research and development.
 
We invest in early-stage biotech companies developing transformative medicine across both mature and novel modalities. Committed to closely following and partnering with entrepreneurs, we share a mission of advancing healthcare for the improvement of lives worldwide.

Key Facts

  • US$ 100 million capital commitment from Eurofarma Laboratorios

  • Agnostic of drug modality and therapeutic indication

  • Focus on therapeutics and platform companies

  • Investment stage: Series A and later, occasionally Seed

  • Maximum of US$ 5million to be invested per company over its investment cycle

  • Geography focus: primarily US and Europe

  • Participation in strong syndicate

Portfolio


  • Pretzel

    Clinical‑stage biotech company advancing first‑in‑class medicines against novel mitochondrial targets. By modulating cellular energetics, the company seeks to redefine treatment approaches for neurodegenerative and rare diseases, as well as prevalent metabolic disorders such as obesity. 

    Learn more: pretzeltx.com 

     

We look forward to connecting and working together. Feel free to reach out if you have an investment idea you would like to share with us. You can easily get in touch using the form in this page.
Click to access Eurofarma Portal
Privacity & Terms